Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Novel murine model of proteinuria developed at Washington University

Dec. 3, 2012

Enrollment complete in pivotal U.S. phase III trial of NX-1207

Nov. 30, 2012

Novel mouse model of NSF developed at Thomas Jefferson University

Nov. 30, 2012

Everolimus approved in new TSC indications in Japan

Nov. 22, 2012

Nymox to commence study evaluating repeat injections of NX-1207

Nov. 22, 2012

Can-Fite BioPharma to develop CF-602 for sexual dysfunction

Nov. 15, 2012

Safety results presented from the AMETHYST-DN study

Nov. 15, 2012

Novel dual NADPH oxidase inhibitor shows excellent safety/pharmacokinetic profile

Nov. 14, 2012

Novel biguanide inhibits cell proliferation and cyst growth of human ADPKD cells

Nov. 13, 2012

Auxilium seeks approval of new indication for Xiaflex in the U.S.

Nov. 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...